| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Institute of Immunology and Transfusion Medicine, Ernst-Moritz-Arndt-University, Greifswald, Germany;
Klinik und Poliklinik für Innere Medizin III, Martin-Luther-Universität, Halle-Wittenberg, Germany; and
Department of Immunology and Cell Biology, Research Center, Borstel, Germany
The soluble form of the endotoxin receptor CD14 is required for the LPS-induced activation of cells lacking membrane-bound CD14. It has been shown that a deletion mutant of human CD14 consisting of the N-terminal 152 amino acids has the capacity to mediate the stimulation of different cell types by LPS. To identify the structural domains of the molecule related to this functional property, we screened a set of alanine substitution mutants using CD14-negative U373 astrocytoma cells. We show that 3 of 18 soluble mutants of human CD14 failed to mediate the LPS-induced IL-6 production in U373 cells. These mutants were located in two regions of the molecule (aa 9–13 and 91–101) that are not essential for LPS binding. In addition, the mutants had a reduced capacity to mediate LPS-stimulated IL-6 production in human vascular endothelial and SMC. In contrast, the potential of sCD14(91–94,96)A, and sCD14(97–101)A to signal LPS-induced activation of human PBMC was not significantly reduced. These results show that the regions 9–13 and 91–101 are involved in the sCD14-dependent stimulation of cells by LPS but that the mechanisms by which different cell types are activated may not be identical.
This article has been cited by other articles:
|
|
 |
|
  K. A. Daly, C. Lefevre, K. Nicholas, E. Deane, and P. Williamson CD14 and TLR4 are expressed early in tammar (Macropus eugenii) neonate development J. Exp. Biol., April 15, 2008; 211(8): 1344 - 1351. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Loppnow, K. Werdan, and M. Buerke Invited review: Vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms Innate Immunity, April 1, 2008; 14(2): 63 - 87. [Abstract] [PDF]
|
|
|
|
|
|
K. Miyake Invited review: Roles for accessory molecules in microbial recognition by Toll-like receptors Innate Immunity, August 1, 2006; 12(4): 195 - 204. [Abstract] [PDF]
|
|
|
|
 |
|
 D. Liu, C. C. Cramer, J. Scafidi, and A. E. Davis III N-Linked Glycosylation at Asn3 and the Positively Charged Residues within the Amino-Terminal Domain of the C1 Inhibitor Are Required for Interaction of the C1 Inhibitor with Salmonella enterica Serovar Typhimurium Lipopolysaccharide and Lipid A Infect. Immun., August 1, 2005; 73(8): 4478 - 4487. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-I. Kim, C. J. Lee, M. S. Jin, C.-H. Lee, S.-G. Paik, H. Lee, and J.-O. Lee Crystal Structure of CD14 and Its Implications for Lipopolysaccharide Signaling J. Biol. Chem., March 25, 2005; 280(12): 11347 - 11351. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Liu, X. Gu, J. Scafidi, and A. E. Davis III N-Linked Glycosylation Is Required for C1 Inhibitor-Mediated Protection from Endotoxin Shock in Mice Infect. Immun., April 1, 2004; 72(4): 1946 - 1955. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. S. Van Amersfoort, T. J. C. Van Berkel, and J. Kuiper Receptors, Mediators, and Mechanisms Involved in Bacterial Sepsis and Septic Shock Clin. Microbiol. Rev., July 1, 2003; 16(3): 379 - 414. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Vanlandschoot, F. Van Houtte, A. Roobrouck, A. Farhoudi, F. Stelter, D. L. Peterson, J. Gomez-Gutierrez, F. Gavilanes, and G. Leroux-Roels LPS-binding protein and CD14-dependent attachment of hepatitis B surface antigen to monocytes is determined by the phospholipid moiety of the particles J. Gen. Virol., September 1, 2002; 83(9): 2279 - 2289. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Baveye, E. Elass, D. G. Fernig, C. Blanquart, J. Mazurier, and D. Legrand Human Lactoferrin Interacts with Soluble CD14 and Inhibits Expression of Endothelial Adhesion Molecules, E-Selectin and ICAM-1, Induced by the CD14-Lipopolysaccharide Complex Infect. Immun., December 1, 2000; 68(12): 6519 - 6525. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
